Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
96.78%
Operating Margin
1.37%
Net Margin
-1.28%
Efficiency Metrics
Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
10.45%
Income Tax Rate
2,300,000,000.0%
EPS
-0.4700000000
Balance Sheet Analysis
Current Ratio
0.09
Cash Ratio
1.00
Working Capital
$-39.45B
Debt to Equity
0.57
Debt to Assets
2.88%
Equity Ratio
5.07%
Cash Flow Analysis
Operating Cash Flow Ratio
136.08%
Free Cash Flow Ratio
135.49%
CapEx to Revenue
0.60%
Dividends Paid
$101.00M
Stock Buybacks
$18.00M
Total Shareholder Returns
$119.00M
Cash Position Change
62.81%
Detailed Growth Metrics
Core Performance
Revenue
103.45%
Net Income
-112.06%
EPS
-111.24%
Operating Income
-90.11%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
47.77%
Operating Cash Flow
83.98%
Free Cash Flow
85.00%
Balance Sheet Health
Assets
27.47%
Debt
56.61%
Book Value per Share
58.47%
Inventory
100.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
7.83%
Long Term Trends
3Y Revenue/Share
283.80%
5Y Revenue/Share
1,011.66%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%